102
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines

, , , , &
Pages 2383-2395 | Published online: 03 Apr 2019

References

  • ItariuBKStulnigTMAutoimmune aspects of type 2 diabetes mellitus – a mini-reviewGerontology201460318919624457898
  • WentworthJMFourlanosSHarrisonLCReappraising the stereotypes of diabetes in the modern diabetogenic environmentNat Rev Endocrinol20095948348919636326
  • GeerlingsSEHoepelmanAIImmune dysfunction in patients with diabetes mellitus (DM)FEMS Immunol Med Microbiol1999263–425926510575137
  • PelegAYWeerarathnaTMcCarthyJSDavisTMCommon infections in diabetes: pathogenesis, management and relationship to glycaemic controlDiabetes Metab Res Rev200723131316960917
  • PollackRMDonathMYLeroithDLeibowitzGAnti-inflammatory agents in the treatment of diabetes and its vascular complicationsDiabetes Care201639Suppl 2S244S25227440839
  • KohKKHanSHQuonMJInflammatory markers and the metabolic syndrome: insights from therapeutic interventionsJ Am Coll Cardiol200546111978198516325028
  • DandonaPAljadaAChaudhuriAMohantyPGargRMetabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammationCirculation2005111111448145415781756
  • RuanHLodishHFInsulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alphaCytokine Growth Factor Rev200314544745512948526
  • El-DeebTSBakkarSMEltoonyLThe adipokine chemerin and fetuin-A serum levels in type 2 diabetes mellitus: relation to obesity and inflammatory markersEgypt J Immunol201825119120230243011
  • HettaHFElkadyAMorsyKHMohamedISIbrahimMASerum level of IL17A among cirrhotic hepatitis C virus infected patients with incidence of diabetes mellitusEgypt J Immunol2017241798829120580
  • HettaHFEz-EldeenMEMohamedGAVisfatin serum levels in obese type 2 diabetic patients: relation to proinflammatory cytokines and insulin resistanceEgypt J Immunol201825214115130600957
  • HettaHFKhairyHMIsmailSMCirculating IL17A and IFN-gamma serum levels in cirrhotic hepatitis C virus infected patients with autoimmune thyroiditisInt J Curr Microbiol Appl Sci20176319721983
  • HettaHFElkadyAMeshaalAKTH17/TH1 role in endocrine disorders among chronic HCV infected patientsInt J Curr Microbiol App Sci20176825422551
  • HotamisligilGSShargillNSSpiegelmanBMAdipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistanceScience1993259509187917678183
  • MaedlerKSergeevPRisFGlucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic isletsJ Clin Invest2002110685186012235117
  • KnöferlMWAngeleMKAyalaACioffiWGBlandKIChaudryIHInsight into the mechanism by which metoclopramide improves immune functions after trauma-hemorrhageAm J Physiol Cell Physiol20002791C72C8010898718
  • ZellwegerRWichmannMWAyalaAChaudryIHMetoclopramide: a novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhageJ Trauma Acute Care Surg19984417077
  • OberbeckRSchmitzDWilsenackKMetoclopramide and cellular immune functions during polymicrobial sepsisEur Surg Res200436211612215007265
  • JarrarDWangPSongGYMetoclopramide: a novel adjunct for improving cardiac and hepatocellular functions after trauma-hemorrhageAm J Physiol Endocrinol Metab20002781E90E9510644541
  • SebakSMirzaeiMMalhotraMKulamarvaAPrakashSHuman serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysisInt J Nanomedicine2010552553220957217
  • LomisNWestfallSFarahdelLMalhotraMShum-TimDPrakashSHuman serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterizationNanomaterials201666E11628335244
  • ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818221839127
  • IbrahimE-SAIsmailSFetihGShaabanOHassaneinKAbdellahNHDevelopment and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal applicationActa Pharm2012621597022472449
  • MohamedRAAbassHAAttiaMAHeikalOAFormulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppositoryJ Pharm Pharmacol201365111607162124102470
  • JenitaJLChocalingamVWilsonBAlbumin nanoparticles coated with polysorbate 80 as a novel drug carrier for the delivery of antiretroviral drug-EfavirenzInt J Pharm Investig201443142
  • AkbarzadehAMehrabiMRMehrabiMRInduction of diabetes by streptozotocin in ratsIndian J Clin Biochem2007222606423105684
  • BancroftJDTheory and Practice of Histological TechniquesNYChurchill Livingstone1982
  • LinWCoombesAGGarnettMCPreparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agentPharm Res19941111158815927532861
  • XuRFisherMJulianoRLTargeted albumin-based nanoparticles for delivery of amphipathic drugsBioconjug Chem201122587087821452893
  • GattaniSGKhabiyaSSAmrutkarJRKushareSSFormulation and evaluation of bilayer tablets of metoclopramide hydrochloride and diclofenac sodiumPDA J Pharm Sci Technol201266215116022492600
  • HemalathaKFormulation and evaluation of metoclopramide hydrochloride microbeads by ionotropic gelation methodInt J Pharm Biol Arch201123
  • MitchellAGPolymorphism in metoclopramide hydrochloride and metoclopramideJ Pharm Pharmacol19853796016042867177
  • MichnikAThermal stability of bovine serum albumin DSC studyJ Therm Anal Calorim2003712509519
  • SathiyanarayananaPKarunakaranaRJGomathibTSudhabPSynthesis and characterization of carboxymethyl cellulose/polyethylene glycol/montmorillonite clay blendsInt J Novel Trends Pharm Sci2015523641
  • Yadav DeepakRAyyappanTShanmugamSSundaramoorthyKVetrichelvanTDevelopment and in-vitro evaluation of buccoadhesive metoclopramide hydrochloride tablet formulationsDevelopment201131516525
  • SebakSMirzaeiMMalhotraMKulamarvaAPrakashSHuman serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysisInt J Nanomed20105525
  • LangerKBalthasarSVogelVDinauerNvon BriesenHSchubertDOptimization of the preparation process for human serum albumin (HSA) nanoparticlesInt J Pharm20032571–216918012711172
  • Radovic-MorenoAFLuTKPuscasuVAYoonCJLangerRFarokhzadOCSurface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibioticsACS Nano2012654279428722471841
  • JunJYNguyenHHChunHSKangBCKoSPreparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation methodFood Chem2011127418921898
  • RahimnejadMJahanshahiMNajafpourGProduction of biological nanoparticles from bovine serum albumin for drug deliveryAfr J Biotechnol2006520
  • HoffmannMAvan MilPJHeat-induced aggregation of beta-lactoglobulin as a function of pHJ Agric Food Chem19994751898190510552468
  • YanSZhangHPiaoJStudies on the preparation, characterization and intracellular kinetics of JD27-loaded human serum albumin nanoparticlesProcedia Eng2015102590601
  • XiaoJLiJCaiLChakrabartiSLiXCytokines and diabetes researchJ Diabetes Res2014201492061324551859
  • YangTTSongSJXueHBShiDFLiuCMLiuHRegulatory T cells in the pathogenesis of type 2 diabetes mellitus retinopathy by miR-155Eur Rev Med Pharmacol Sci201519112010201526125263
  • Fernández-RealJMBrochMRicartWPlasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistanceDiabetes19984711175717629792545
  • de LucaCOlefskyJMInflammation and insulin resistanceFEBS Lett200858219710518053812
  • JagerJGrémeauxTCormontMLe Marchand-BrustelYTantiJFInterleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expressionEndocrinology2007148124125117038556
  • MccallumRWSowersJRHershmanJMSturdevantRAMetoclopramide stimulates prolactin secretion in manJ Clin Endocrinol Metab197642611481152777023
  • McNeillyAThornerMVolansGBesserGMetaclopramide and prolactinBr Med J197425921729
  • HealyDLBurgerHGIncreased prolactin and thyrotrophin secretion following oral metoclopramide: dose-response relationshipsClin Endocrinol197773195201
  • FalaschiPFrajeseGSciarraFRoccoAContiCInfluence of hyperprolactinaemia due to metoclopramide on gonadal function in menClin Endocrinol197885427433
  • Van den BergheGde ZegherFAnterior pituitary function during critical illness and dopamine treatmentCrit Care Med1996249158015908797634
  • ZhuXHZellwegerRAyalaAChaudryIHProlactin inhibits the increased cytokine gene expression in Kupffer cells following haemorrhageCytokine1996821341408777271
  • ZhengYRudenskyAYFOXP3 in control of the regulatory T cell lineageNat Immunol20078545746217440451
  • HettaHFMekkyMAKhalilNKAssociation of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathologyJ Gastroenterol Hepatol201530101543155125708446
  • MehtaMHettaHFAbdel-HameedEAAssociation between IL28b rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patientsArch Virol2016161113161316927544760
  • ZahranAMMohammed SalehMFSayedMMRayanAAliAMHettaHFUp-regulation of regulatory T cells, CD200 and Tim3 expression in cytogenetically normal acute myeloid leukemiaCancer Biomark201822358759529843224
  • ZahranAMZharanKMHettaHFSignificant correlation between regulatory T cells and vitamin D status in term and preterm laborJ Reprod Immunol2018129152230029057
  • Guzmán-FloresJMPortales-PérezDPMecanismos de supresión de las células T reguladoras (Treg) [Mechanisms of suppression of regulatory T-cells (Treg)]Gac Med Mex20131496630638 Spanish24276186
  • BergonziMCGuccioneCGrossiCAlbumin nanoparticles for brain delivery: a comparison of chemical versus thermal methods and in vivo behaviorChemMedChem201611161840184926947767
  • ShiloMSharonABaranesKMotieiMLelloucheJPMPopovtzerRThe effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell modelJ Nanobiotechnol201513119
  • MariamJSivakamiSDongrePMAlbumin corona on nanoparticles-a strategic approach in drug deliveryDrug Deliv20162382668267626056719
  • MohamedJNazratun NafizahAHZariyanteyAHBudinSBMechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammationSultan Qaboos Univ Med J2016162e132e14127226903
  • RegnellSELernmarkÅHepatic steatosis in type 1 diabetesRev Diabet Stud20118445422580727
  • StefanNSunQFritscheAImpact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studiesPLoS One201493e9223824643166
  • LongoDKasperDKauserSLoscalzoJFauciAJamesonJHarrison’s Principle of Internal MedicineEdisi ke-18New YorkMcGraw-Hill2011
  • Al-HussainiAASulaimanNMAlzahraniMDAleniziASKhanMPrevalence of hepatopathy in type 1 diabetic childrenBMC Pediatr201212116023039762
  • EbaidHAl-TamimiJMetwalliAEffect of STZ-induced diabetes on spleen of rats: improvement by camel whey proteinsPakistan J Zool201547411091116
  • EbaidHPromotion of immune and glycaemic functions in streptozotocin-induced diabetic rats treated with un-denatured camel milk whey proteinsNutr Metab201411131
  • ParkGBKimYSLeeHKChoDHKimDHurDYCD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathwayInt J Oncol20134351531154024008628
  • WangNSunHShenYAugmenter of liver regeneration inhibits apoptosis of activated human peripheral blood lymphocytes in vitroImmuno Immunotoxicol2013352257263
  • JaberBMPetroianuGARizviSAProtective effect of metoclopramide against organophosphate-induced apoptosis in the murine skin fibroblast L929J Appl Toxicol201838332934029027213